24577874Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu Y, Schwartz JD, Thompson JACancerAntibodies, Monoclonal; Carcinoma, Renal Cell; Kidney Neoplasms; Protein Kinase Inhibitors; Vascular Endothelial Growth Factor Receptor-2Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Female; Humans; Male; Middle Aged; RamucirumabA phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Cancer. 2014 Jun 01; 120(11):1647-55.Cancer2014-02-27T00:00:002014A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD000911Chemicals & Drugs33713760.622785Antibodies, MonoclonalD002292Disorders1134250.717118Carcinoma, Renal CellD007680Disorders1406200.652846Kidney NeoplasmsD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD005260Physiology1992444050.191184FemaleD006801Living Beings2262862810.130064HumansD014408Chemicals & Drugs32614610.548135Biomarkers, TumorD008297Physiology1931408600.201635MaleD018450Physiology49815310.700876Disease ProgressionD040301Chemicals & Drugs46810.964171Vascular Endothelial Growth Factor Receptor-2D061067Chemicals & Drugs2139290.656201Antibodies, Monoclonal, HumanizedAuthorship 6451240.1242790.1242791authors10.2516has subject areaD018572Concepts & Ideas25812030.792724Disease-Free SurvivalD047428Chemicals & Drugs2065890.714226Protein Kinase InhibitorsMedicineUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.Professortrue1ProfessorProfessor